Logo image of ALECO.PA

ECOMIAM SA (ALECO.PA) Stock Fundamental Analysis

EPA:ALECO - Euronext Paris - Matif - FR0013534617 - Common Stock - Currency: EUR

2.98  0 (0%)

Fundamental Rating

4

ALECO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 28 industry peers in the Consumer Staples Distribution & Retail industry. ALECO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALECO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALECO has reported negative net income.
ALECO had a negative operating cash flow in the past year.
In multiple years ALECO reported negative net income over the last 5 years.
ALECO had negative operating cash flow in 4 of the past 5 years.
ALECO.PA Yearly Net Income VS EBIT VS OCF VS FCFALECO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M

1.2 Ratios

ALECO has a worse Return On Assets (-24.87%) than 92.86% of its industry peers.
With a Return On Equity value of -46.63%, ALECO is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -24.87%
ROE -46.63%
ROIC N/A
ROA(3y)-25.33%
ROA(5y)-12.63%
ROE(3y)-57.45%
ROE(5y)-9.56%
ROIC(3y)N/A
ROIC(5y)N/A
ALECO.PA Yearly ROA, ROE, ROICALECO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

With an excellent Gross Margin value of 39.84%, ALECO belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
ALECO's Gross Margin has improved in the last couple of years.
ALECO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y4.19%
ALECO.PA Yearly Profit, Operating, Gross MarginsALECO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

ALECO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALECO has been increased compared to 1 year ago.
The number of shares outstanding for ALECO has been increased compared to 5 years ago.
Compared to 1 year ago, ALECO has an improved debt to assets ratio.
ALECO.PA Yearly Shares OutstandingALECO.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALECO.PA Yearly Total Debt VS Total AssetsALECO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

ALECO has an Altman-Z score of 3.43. This indicates that ALECO is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ALECO (3.43) is better than 64.29% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that ALECO is not too dependend on debt financing.
ALECO has a Debt to Equity ratio of 0.21. This is amongst the best in the industry. ALECO outperforms 96.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 3.43
ROIC/WACCN/A
WACC7.32%
ALECO.PA Yearly LT Debt VS Equity VS FCFALECO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

ALECO has a Current Ratio of 2.57. This indicates that ALECO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.57, ALECO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ALECO has a Quick Ratio of 1.72. This is a normal value and indicates that ALECO is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALECO (1.72) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.72
ALECO.PA Yearly Current Assets VS Current LiabilitesALECO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.42% over the past year.
Looking at the last year, ALECO shows a decrease in Revenue. The Revenue has decreased by -2.57% in the last year.
Measured over the past years, ALECO shows a very strong growth in Revenue. The Revenue has been growing by 22.39% on average per year.
EPS 1Y (TTM)62.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.52%
Revenue 1Y (TTM)-2.57%
Revenue growth 3Y3.67%
Revenue growth 5Y22.39%
Sales Q2Q%0.15%

3.2 Future

The Earnings Per Share is expected to grow by 65.47% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALECO will show a quite strong growth in Revenue. The Revenue will grow by 19.23% on average per year.
EPS Next Y111.9%
EPS Next 2Y65.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.42%
Revenue Next 2Y19.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALECO.PA Yearly Revenue VS EstimatesALECO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
ALECO.PA Yearly EPS VS EstimatesALECO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALECO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 57.86, ALECO can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ALECO is valued more expensive than 89.29% of the companies in the same industry.
ALECO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 57.86
ALECO.PA Price Earnings VS Forward Price EarningsALECO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALECO.PA Per share dataALECO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALECO's earnings are expected to grow with 65.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y65.47%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALECO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECOMIAM SA

EPA:ALECO (3/7/2025, 7:00:00 PM)

2.98

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)08-01 2024-08-01
Earnings (Next)N/A N/A
Inst Owners0.83%
Inst Owner ChangeN/A
Ins Owners3.45%
Ins Owner ChangeN/A
Market Cap15.97M
Analysts86.67
Price Target3.57 (19.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 57.86
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 2.34
P/tB 2.44
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)0.05
Fwd EY1.73%
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS7.53
BVpS1.27
TBVpS1.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.87%
ROE -46.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.84%
FCFM N/A
ROA(3y)-25.33%
ROA(5y)-12.63%
ROE(3y)-57.45%
ROE(5y)-9.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.82%
GM growth 5Y4.19%
F-Score4
Asset Turnover3.15
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 135.82%
Cap/Sales 0.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 1.72
Altman-Z 3.43
F-Score4
WACC7.32%
ROIC/WACCN/A
Cap/Depr(3y)90.44%
Cap/Depr(5y)244.65%
Cap/Sales(3y)1.42%
Cap/Sales(5y)2.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.52%
EPS Next Y111.9%
EPS Next 2Y65.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.57%
Revenue growth 3Y3.67%
Revenue growth 5Y22.39%
Sales Q2Q%0.15%
Revenue Next Year16.42%
Revenue Next 2Y19.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year150%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.8%
OCF growth 3YN/A
OCF growth 5YN/A